Cystic Fibrosis WA State Chptr - WA King, Seattle 98101

Cystic Fibrosis WA State Chptr entered the industry of Medical Research in 0 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 8139100, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.

To acquire more information, please contact Dottie Moore, Executive Director by calling (206) 282-4770 during business hours. You can also write to the business’ Single Location at 520 Pike St # 1075, Seattle, Washington WA 98101. You can also visit the company’s website at cff.org. View this business’ social media profiles on Twitter or on Facebbok .

Company: Cystic Fibrosis WA State Chptr
Representative: Dottie Moore, Executive Director
Place of Business: 520 Pike St # 1075, Seattle, WA 98101
Contact Number: (206) 282-4770
Website: cff.org
Type of Service: Medical Research
SIC Number: 8733
NAICS Number: 8139100
Locality: Single Location
Market Type: B2B (Business to Business)
Income/Year: Unknown
Laborers: 1 to 4
Share This Company:

Cystic Fibrosis WA State Chptr is a company operating from King, Washington providing professional Medical Research and relevant B2B variables. It was founded in 0 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 8139100 as Medical Research.

With a current employee count of 1 to 4, Cystic Fibrosis WA State Chptr has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Dottie Moore, Executive Director at (206) 282-4770 for related queries, or to locate its Single Location using the coordinates 47.610834,-122.335378.

The Single Location can also be found at the street address 520 Pike St # 1075 in Seattle, Washington 98101 and can be engaged online through the company website at cff.org, the company Twitter , and Facebook page .